1429877-17-7

Basic information

• Product Name: 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}[1,3]dioxolan-2-yl)ethyl]benzoic acid
• Synonyms: 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}[1,3]dioxolan-2-yl)ethyl]benzoic acid
• CAS NO: 1429877-17-7
• Molecular Weight: 485.967
• Mol File: 1429877-17-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}[1,3]dioxolan-2-yl)ethyl]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}[1,3]dioxolan-2-yl)ethyl]benzoic acid(1429877-17-7)
• EPA Substance Registry System: 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}[1,3]dioxolan-2-yl)ethyl]benzoic acid(1429877-17-7)

Safety Data

• Hazardous Substances Data: 1429877-17-7(Hazardous Substances Data)

Upstream product

• 149968-11-6 methyl 2-(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-oxopropyl)benzoate 
• 1258428-69-1 methyl 2-[2-(2-{3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl}-1,3dioxolan-2-yl)ethyl]benzoate 

Relevant articles and documents

CYSTEINYL LEUKOTRIENE ANTAGONISTS

The present invention relates to novel cysteinyl leukotriene (specifically LTD4) antagonists, mainly to quinolin, quinoxaline or benz[c]thiazole derivatives represented by the general formula (I), or the pharmaceutically acceptable salt thereof, process of preparation thereof, and to the use of the compounds in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to cysteinyl leukotriene, in mammals, more specially in humans.